Assessing Medicaid Coverage for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy: A Project from the American Society for Transplantation and Cellular Therapy and the National Marrow Donor Program ACCESS Initiative
Jeffery J. Auletta(Nationwide Children's Hospital), Navneet S. Majhail(Sarah Cannon), Alycia Maloney, Jessica Knutson(National Marrow Donor Program), Patrick DeMartino(Oregon Health & Science University), Nandita Khera(Mayo Clinic in Florida), Amar H. Kelkar(Harvard University), Rafeek A. Yusuf(National Marrow Donor Program), Ellie Beaver(National Marrow Donor Program), Stella M. Davies(Cincinnati Children's Hospital Medical Center)
Cited by 25
Related Papers
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
|Nature Medicine|2018|577
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
|Blood|2016|554
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|442
Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation
|Biology of Blood and Marrow Transplantation|2015|409
Recommended Screening and Preventive Practices for Long-Term Survivors after Hematopoietic Cell Transplantation
|Biology of Blood and Marrow Transplantation|2011|363